Citation: Hz. Fan et al., THE R1 COMPONENT OF MAMMALIAN RIBONUCLEOTIDE REDUCTASE HAS MALIGNANCY-SUPPRESSING ACTIVITY AS DEMONSTRATED BY GENE-TRANSFER EXPERIMENTS, Proceedings of the National Academy of Sciences of the United Statesof America, 94(24), 1997, pp. 13181-13186
Citation: Ap. Huang et al., RIBONUCLEOTIDE REDUCTASE R2 GENE-EXPRESSION AND CHANGES IN DRUG-SENSITIVITY AND GENOME STABILITY, Cancer research, 57(21), 1997, pp. 4876-4881
Citation: Ap. Huang et Ja. Wright, GROWTH-FACTOR REGULATION OF GENETIC STABILITY AND A POSSIBLE ROLE FORORNITHINE DECARBOXYLASE, A POTENTIAL TARGET FOR GENE-THERAPY, Cancer gene therapy, 3(6), 1996, pp. 71-71
Citation: Hz. Fan et al., SUPPRESSION OF MALIGNANCY BY THE 3' UNTRANSLATED REGIONS OF RIBONUCLEOTIDE REDUCTASE R1 AND R2 MESSENGER-RNAS, Cancer research, 56(19), 1996, pp. 4366-4369
Citation: Ap. Huang et al., MULTIPLE EFFECTS ON DRUG-SENSITIVITY, GENOME STABILITY AND MALIGNANT POTENTIAL BY COMBINATIONS OF H-RAS, C-MYC AND MUTANT P53 GENE OVEREXPRESSION, International journal of oncology, 7(1), 1995, pp. 57-63
Citation: Ap. Huang et al., DRUG-RESISTANCE AND GENE AMPLIFICATION POTENTIAL REGULATED BY TRANSFORMING GROWTH-FACTOR BETA(1) GENE-EXPRESSION, Cancer research, 55(8), 1995, pp. 1758-1762
Citation: Fm. Amara et al., ALTERED REGULATION OF MESSAGE STABILITY AND TUMOR PROMOTER-RESPONSIVECIS-TRANS INTERACTIONS OF RIBONUCLEOTIDE REDUCTASE R1 AND R2 MESSENGER-RNAS IN HYDROXYUREA-RESISTANT CELLS, Cancer research, 55(20), 1995, pp. 4503-4506